Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700027	重组人-鼠嵌合抗CD20单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2017-07-13	喜康（武汉）生物医药有限公司	Xikang(Wuhan)Biopharmaceutical Co Ltd	Certificate Issued	2018-06-28	view
CXSL1200088	重组人-鼠嵌合抗CD20单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2013-02-04	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2014-09-24	view
CXSL1100072	重组人-鼠嵌合抗CD20单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2012-02-24	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2014-02-13	view